Hepatitis C viral recurrence in a pediatric patient following liver transplantation

Pediatric Transplantation

Volumn 10, Issue 5, 2006, Pages 617-622

  Udell, Ian W ^a   Barshes, Neal R ^a   Finegold, Milton J ^b   Lee, Timothy C ^a   Scott, Jaymee D ^a   Carter, Beth ^a   Karpen, Saul ^a   Goss, John A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; ASCITES; CASE REPORT; DISEASE COURSE; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS VARICES; FEMALE; HEMATEMESIS; HEPATITIS C VIRUS; HISTORY OF MEDICINE; HOSPITALIZATION; HUMAN; LIVER BIOPSY; LIVER TRANSPLANTATION; PEDIATRIC SURGERY; RECURRENT DISEASE; SCAR FORMATION; VERTICAL TRANSMISSION; VIRUS INFECTION;

ADOLESCENT; ANTIVIRAL AGENTS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEPATITIS C; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LIVER TRANSPLANTATION; RECURRENCE;

EID: 33745699192     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00519.x     Document Type: Article

References (57)

1. ALTER MJ, KRUSZON-MORAN D, NAINAN OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999: 341: 556-562.
2. WEINTRAUB PS. Viral hepatitis. In: HOFFMAN JIE, RUDOLPH CD, eds. Rudolph's Pediatrics. Stanford, CT: Appleton and Lange, 1996: pp. 647-651.
3. FRAYHA HH. Hepatitis viruses A through G. In: ELZOUKI AY, HARFI HA, NAZER H, eds. Textbook of Clinical Pediatrics. Philadelphia, PA: Lippincott Williams and Wilkins, 2001: pp. 390-401.
4. KESSON AM. Diagnosis and management of paediatric hepatitis C virus infection. J Paediatr Child Health 2002: 38: 213-218.
5. BADIZADEGAN K, JONAS MM, OTT MJ, NELSON SP, PEREZ-ATAYDE AR. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 1998: 28: 1416-1423.
6. CASTELLINO S, LENSING S, RIELY C, et al. The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort. Blood 2004: 103: 2460-2466.
7. VOGT M, LANG T, FROSNER G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 1999: 341: 866-870.
8. KAGE M, FUJISAWA T, SHIRAKI K, et al. Pathology of chronic hepatitis C in children. Child Liver Study Group of Japan. Hepatology 1997: 26: 771-775.
9. BORTOLOTTI F, JARA P, DIAZ C, et al. Posttransfusion and community-acquired hepatitis C in childhood. J Pediatr Gastroenterol Nutr 1994: 18: 279-283.
10. JARA P, RESTI M, HIERRO L, et al. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis 2003: 36: 275-280.
11. MATSUOKA S, TATARA K, HAYABUCHI Y, et al. Serologic, virologic, and histologic characteristics of chronic phase hepatitis C virus disease in children infected by transfusion. Pediatrics 1994: 94: 919-922.
12. Tovo PA, PEMBREY LJ, NEWELL ML. Persistence rate and progression of vertically acquired hepatitis C infection. European Paediatric Hepatitis C Virus Infection. J Infect Dis 2000: 181: 419-424.
13. RESTI M, JARA P, HIERRO L, et al. Clinical features and progression of perinatally acquired hepatitis C virus infection. J Med Virol 2003: 70: 373-377.
14. SASAKI N, MATSUI A, MOMOI M, TSUDA F, OKAMOTO H. Loss of circulating hepatitis C virus in children who developed a persistent carrier state after mother-to-baby transmission. Pediatr Res 1997: 42: 263-267.
15. CASIRAGHI MA, DE PASCHALE M, ROMANO L, et al. Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology 2004: 39: 90-96.
16. DELGADO-BORREGO A, JONAS MM. Treatment options for hepatitis C infection in children. Curr Treat Options Gastroenterol 2004: 7: 373-379.
17. GONZALEZ-PERALTA RP. Treatment of chronic hepatitis C in children. Pediatr Transplant 2004: 8: 639-643.
18. GUIDO M, BORTOLOTTI F, LEANDRO G, et al. Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time? Am J Gastroenterol 2003: 98: 660-663.
19. MCDIARMID SV, CONRAD A, AMENT ME, et al. De novo hepatitis C in children after liver transplantation. Transplantation 1998: 66: 311-318.
20. DUSSAIX E, DE PAILLETTE L, LAURENT-PUIG P, et al. Hepatitis C virus infection in pediatric liver transplantation. Transplantation 1993: 55: 795-798.
21. BIRNBAUM AH, SHNEIDER BL, MOY L. Hepatitis C in children. N Engl J Med 2000: 342: 290-291.
22. DOVE LM. Management of hepatitis C after transplantation: a long way from success. Eur J Gastroenterol Hepatol 2004: 16: 1131-1133.
23. SANCHEZ-FUEYO A, RESTREPO JC, QUINTO L, et al. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft. Transplantation 2002: 73: 56-63.
24. TESTA G, CRIPPIN JS, NETTO GJ, et al. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transpl 2000: 6: 553-561.
25. BERENGUER M, PRIETO M, PALAU A, et al. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis. Liver Transpl 2003: 9: 228-235.
26. RODRIGUEZ-LUNA H, VARGAS HE. Management of hepatitis C virus infection in the setting of liver transplantation. Liver Transpl 2005: 11: 479-489.
27. PELLETIER SJ, SCHAUBEL DE, PUNCH JD, WOLFE RA, PORT FK, MERION RM. Hepatitis C is a risk factor for death after liver retransplantation. Liver Transpl 2005: 11: 434-440.
28. BERENGUER M, CRIPPIN J, GISH R, et al. A model to predict severe HCV-related disease following liver transplantation. Hepatology 2003: 38: 34-41.
29. BERENGUER M. Natural history of recurrent hepatitis C. Liver Transpl 2002: 8: S14-S18.
30. BERENGUER M, FERRELL L, WATSON J, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000: 32: 673-684.
31. EVERSON GT, TROTTER J. Role of adult living donor liver transplantation in patients with hepatitis C. Liver Transpl 2003: 9: S64-S68.
32. GAGLIO PJ, MALIREDDY S, LEVITT BS, et al. Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors. Liver Transpl 2003: 9: 1028-1035.
33. GARCIA-RETORTILLO M, FORNS X, LLOVET JM, et al. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology 2004: 40: 699-707.
34. RUSSO MW, GALANKO J, BEAVERS K, FRIED MW, SHRESTHA R. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Liver Transpl 2004: 10: 340-346.
35. RODRIGUEZ-LUNA H, VARGAS HE, SHARMA P, et al. Hepatitis C virus recurrence in living donor liver transplant recipients. Dig Dis Sci 2004: 49: 38-41.
36. BOZORGZADEH A, JAIN A, RYAN C, et al. Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus. Transplantation 2004: 77: 1066-1070.
37. SHIFFMAN ML, STRAVITZ RT, CONTOS MJ, et al. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl 2004: 10: 1248-1255.
38. GANE EJ, NAOUMOV NV, QIAN KP, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996: 110: 167-177.
39. SHEINER PA, SCHWARTZ ME, MOR E, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995: 21: 30-34.
40. LAKE JR. The role of immunosuppression in recurrence of hepatitis C. Liver Transpl 2003: 9: S63-S66.
41. JAIN A, KASHYAP R, DEMETRIS AJ, EGHSTESAD B, POKHARNA R, FUNG JJ. A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C. Liver Transpl 2002: 8: 40-46.
42. WIESNER R, RABKIN J, KLINTMALM G, et al. A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients. Liver Transpl 2001: 7: 442-450.
43. FASOLA CG, NETTO GJ, JENNINGS LW, et al. Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil. Transplant Proc 2002: 34: 1563-1564.
44. FASOLA CG, NETTO GJ, CHRISTENSEN LL, et al. Delay of hepatitis C recurrence in liver transplant recipients: impact of mycophenolate mofetil on transplant recipients with severe acute rejection or with renal dysfunction. Transplant Proc 2002: 34: 1561-1562.
45. IORIO R, PENSATI P, BOTTA S, et al. Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis. Pediatr Infect Dis J 1997: 16: 984-990.
46. WIRTH S, LANG T, GEHRING S, GERNER P. Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C. Hepatology 2002: 36: 1280-1284.
47. LACKNER H, MOSER A, DEUTSCH J, et al. Interferon-alpha and ribavirin in treating children and young adults with chronic hepatitis C after malignancy. Pediatrics 2000: 106: E53.
48. BIGGINS SW, TERRAULT NA. Treatment of recurrent hepatitis C after liver transplantation. Clin Liver Dis 2005: 9: ix.
49. SHEINER PA, BOROS P, KLION FM, et al. The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology 1998: 28: 831-838.
50. SINGH N, GAYOWSKI T, WANNSTEDT CF, MARINO IR, WAGENER MM. Interferon-alpha therapy for hepatitis C virus recurrence after liver transplantation: long-term response with maintenance therapy. Clin Transplant 1996: 10: 348-351.
51. WRIGHT HI, GAVALER JS, VAN THEIL DH. Preliminary experience with alpha-2b-interferon therapy of viral hepatitis in liver allograft recipients. Transplantation 1992: 53: 121-124.
52. WRIGHT TL, DONEGAN E, HSU HH, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992: 103: 317-322.
53. DAVIS GL. Treatment of acute and chronic hepatitis C. Clin Liver Dis 1997: 1: 615-630.
54. JACOBSON KR, MURRAY K, ZELLOS A, SCHWARZ KB. An analysis of published trials of interferon monotherapy in children with chronic hepatitis C. J Pediatr Gastroenterol Nutr 2002: 34: 52-58.
55. MOLMENTI E, MAZARIEGOS G, BUENO J, et al. Noncompliance after pediatric liver transplantation. Transplant Proc 1999: 31: 408.
56. SHEMESH E. Non-adherence to medications following pediatric liver transplantation. Pediatr Transplant 2004: 8: 600-605.
57. FALKENSTEIN K, FLYNN L, KIRKPATRICK B, CASA-MELLEY A, DUNN S. Non-compliance in children post-liver transplant. Who are the culprits? Pediatr Transplant 2004: 8: 233-236.